Cytocom: Cytocom to fund research and laboratory facilities at La Jolla Institute for Immunology
Cytocom, Inc., a leading biopharmaceutical company creating next─generation immune therapies that focus on immune restoration and homeostasis, announced a collaboration agreement to fund research and
Read full article »
Cytocom is a Colorado-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of autoimmune and cancer diseases.
Read more